John T. Henderson, Director at MYRIAD GENETICS INC (MYGN), sold 20,000 shares at $30.31 ($606K) on 2017-09-01, disclosed to the SEC on 2017-09-05.
Open-market sale of $606k MYGN by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $30.30 | 10,000 | $303K | 50.0% |
| 2 | $30.31 | 10,000 | $303K | 50.0% |
| Total | $30.30 avg | 20,000 | $606K | 100% |
| Filing → |
| CYTK | SELL | 2025-04-16 | $247K | — | Filing → |
| CYTK | SELL | 2024-12-12 | $179K | — | Filing → |
| CYTK | SELL | 2024-04-25 | $1.4M | — | Filing → |